Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN KODAK COKODK · Entity 5053 | General Counsel, Sec., SVP | December 15, 2018 | January 11, 2019 |
| IDEXX LABORATORIES INC /DEIDXX · Entity 3057 | EVP, GC & Corporate Secretary | March 03, 2026 | March 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN KODAK CO
Report date December 15, 2018 · Filed January 11, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.84 · Expires 2025-12-14 | Direct | 139,665 |
Reported balance
After 2018-12-15 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-12-15 · Grant · Acquired 139,665 · Balance 139,665 F1: Ms. Underberg previously reported this option on her 12/15/2018 Form 4; however, at that time, the number of shares underlying the option could not be determined. Ms. Underberg is filing this amendment to report the number of shares underlying the option. This option vests one-third on each of the first three anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Ms. Underberg previously reported this option on her 12/15/2018 Form 4; however, at that time, the number of shares underlying the option could not be determined. Ms. Underberg is filing this amendment to report the number of shares underlying the option. This option vests one-third on each of the first three anniversaries of the grant date.
IDEXX LABORATORIES INC /DE
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,137.654 |
Reported balance
After 2026-03-03 transaction · row 1
1 source rowRow 1 · 2026-03-03 · Exercise / conversion · Acquired 197 · Balance 7,137.654 |
| Incentive Stock Option (right-to-buy)SEC Table II · derivative / convertible security · Conversion / exercise price $505.53 · Expires 2032-02-13 | Direct | 0 |
Reported balance
After 2026-03-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-03 · Exercise / conversion · Disposed 197 · Balance 0 F2: Not applicable. F1: Grant of option to buy shares of Issuer common stock that vested on February 14, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of option to buy shares of Issuer common stock that vested on February 14, 2026.
F2: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 8 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370 Underlying: Common Stock · 138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. F5 · price: Not applicable. F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 216 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 7 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,508 Underlying: Common Stock · 216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F5 · price: Not applicable. F2 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F2 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 6 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,724 Underlying: Common Stock · 483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F5 · price: Not applicable. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 305 | $503.65 | $153,613.25 |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 5 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,746.9949 Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 4 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,051.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 3 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,878.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 216 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 2 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,740.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:56 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 483 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,524.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 704 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-23-002397 · doc1.xml · derivative · entry 4 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,207 Underlying: Common Stock · 704 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. F5 · price: Not applicable. F4 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. F4 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantIncentive Stock Option (right-to-buy) · Derivative | 201 | Not disclosed Strike: $497.43 | Not disclosed |
DisclosureSEC source: 0001567619-23-002397 · doc1.xml · derivative · entry 3 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201 Underlying: Common Stock · 201 shares Expires 2033-02-07 F5 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2027. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 4,949 | Not disclosed Strike: $497.43 | Not disclosed |
DisclosureSEC source: 0001567619-23-002397 · doc1.xml · derivative · entry 2 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,949 Underlying: Common Stock · 4,949 shares Expires 2033-02-07 F5 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2024. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 22:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 483 | Not disclosed Strike: $206.94 | Not disclosed |
DisclosureSEC source: 0001567619-22-005125 · doc1.xml · derivative · entry 2 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966 Underlying: Common Stock · 483 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 22:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 483 | $206.94 | $99,952.02 |
DisclosureSEC source: 0001567619-22-005125 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,986.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · derivative · entry 10 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,503 Underlying: Common Stock · 138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. F8 · price: Not applicable. F7 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. F7 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · derivative · entry 9 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,641 Underlying: Common Stock · 217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F8 · price: Not applicable. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · derivative · entry 8 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,858 Underlying: Common Stock · 483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F8 · price: Not applicable. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 692 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · derivative · entry 7 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,341 Underlying: Common Stock · 692 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. F8 · price: Not applicable. F4 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. F4 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantIncentive Stock Option (right-to-buy) · Derivative | 197 | Not disclosed Strike: $505.53 | Not disclosed |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · derivative · entry 6 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197 Underlying: Common Stock · 197 shares Expires 2032-02-13 F8 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 5,917 | Not disclosed Strike: $505.53 | Not disclosed |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · derivative · entry 5 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,917 Underlying: Common Stock · 5,917 shares Expires 2032-02-13 F8 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 253 | $505.53 | $127,899.09 |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · nonDerivative · entry 4 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,503.9949 Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · nonDerivative · entry 3 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,756.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 217 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · nonDerivative · entry 2 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,618.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 00:29 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 483 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-004789 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,401.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 40.9949 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 483 | Not disclosed Strike: $206.94 | Not disclosed |
DisclosureSEC source: 0001567619-21-004796 · doc1.xml · derivative · entry 2 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,449 Underlying: Common Stock · 483 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 483 | $206.94 | $99,952.02 |
DisclosureSEC source: 0001567619-21-004796 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · derivative · entry 8 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,649 Underlying: Common Stock · 217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F8 · price: Not applicable. F7 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F7 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · derivative · entry 7 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,866 Underlying: Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F8 · price: Not applicable. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · derivative · entry 6 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,349 Underlying: Common Stock · 551 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. F8 · price: Not applicable. F5 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. F5 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantIncentive Stock Option (right-to-buy) · Derivative | 183 | Not disclosed Strike: $544.08 | Not disclosed |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · derivative · entry 5 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183 Underlying: Common Stock · 183 shares Expires 2031-02-13 F2 · derivative.exercise_price: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021. F8 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 5,119 | Not disclosed Strike: $544.08 | Not disclosed |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · derivative · entry 4 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,119 Underlying: Common Stock · 5,119 shares Expires 2031-02-13 F2 · derivative.exercise_price: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021. F8 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 208 | $544.08 | $113,168.64 |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · nonDerivative · entry 3 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,395 Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 217 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · nonDerivative · entry 2 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 00:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 483 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-004330 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 29 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2020 and December 31, 2020. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 483 | Not disclosed Strike: $206.94 | Not disclosed |
DisclosureSEC source: 0001567619-20-015833 · doc1.xml · derivative · entry 2 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,932 Underlying: Common Stock · 483 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 483 | $206.94 | $99,952.02 |
DisclosureSEC source: 0001567619-20-015833 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 38 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2020 and June 30, 2020. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004374 · doc1.xml · derivative · entry 5 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,798 Underlying: Common Stock · 484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F5 · price: Not applicable. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004374 · doc1.xml · derivative · entry 4 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 866 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F5 · price: Not applicable. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F3 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 8,906 | Not disclosed Strike: $288.78 | Not disclosed |
DisclosureSEC source: 0001567619-20-004374 · doc1.xml · derivative · entry 3 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,906 Underlying: Common Stock · 8,906 shares Expires 2030-02-13 F5 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2021. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 153 | $288.78 | $44,183.34 |
DisclosureSEC source: 0001567619-20-004374 · doc1.xml · nonDerivative · entry 2 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353 Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:35 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 484 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004374 · doc1.xml · nonDerivative · entry 1 Underberg Sharon E. · CIK 0001630353 · CVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 22 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2019. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | GrantStock Option (Right to Buy) · Derivative | 0 | $0.00 Strike: $2.84 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · derivative · entry 16 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.01 · Not disclosed shares Expires 2025-12-14 F10 · shares: This option was granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and vests one-third on each of the first three anniversaries of the 12/15/2018 grant date. The number of shares underlying the option cannot be determined at this time, but will be based on $250,000 divided by the Black-Scholes valuation of the option on the grant date. Once the number is determined, Ms. Underberg will file an amendment to this report. F10 · derivative.exercise_date: This option was granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and vests one-third on each of the first three anniversaries of the 12/15/2018 grant date. The number of shares underlying the option cannot be determined at this time, but will be based on $250,000 divided by the Black-Scholes valuation of the option on the grant date. Once the number is determined, Ms. Underberg will file an amendment to this report. F10 · derivative.underlying_shares: This option was granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and vests one-third on each of the first three anniversaries of the 12/15/2018 grant date. The number of shares underlying the option cannot be determined at this time, but will be based on $250,000 divided by the Black-Scholes valuation of the option on the grant date. Once the number is determined, Ms. Underberg will file an amendment to this report. F10 · balance_after: This option was granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and vests one-third on each of the first three anniversaries of the 12/15/2018 grant date. The number of shares underlying the option cannot be determined at this time, but will be based on $250,000 divided by the Black-Scholes valuation of the option on the grant date. Once the number is determined, Ms. Underberg will file an amendment to this report. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | GrantRestricted Stock Units · Derivative | 88,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · derivative · entry 11 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,029 Underlying: Common Stock, par value $.01 · 88,029 shares Expires 2021-12-15 F5 · derivative.exercise_price: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and vest one-third on each of the first three anniversaries of the 12/15/2018 grant date. F5 · derivative.exercise_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Company's 2013 Omnibus Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and vest one-third on each of the first three anniversaries of the 12/15/2018 grant date. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Exercise / conversionRestricted Stock Units · Derivative | 24,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · derivative · entry 10 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,752 Underlying: Common Stock, par value $.01 · 24,875 shares Expires 2020-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These restricted stock units, which convert into common stock on a one-for-one basis, vest one-third on each of the first three anniversaries of the 12/15/2017 grant date. F4 · derivative.exercise_date: These restricted stock units, which convert into common stock on a one-for-one basis, vest one-third on each of the first three anniversaries of the 12/15/2017 grant date. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Exercise / conversionRestricted Stock Units · Derivative | 5,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · derivative · entry 9 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,099 Underlying: Common Stock, par value $.01 · 5,096 shares Expires 2019-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These restricted stock units, which convert into common stock on a one-for-one basis, vest one-third on each of the first three anniversaries of the 12/15/2016 grant date. F3 · derivative.exercise_date: These restricted stock units, which convert into common stock on a one-for-one basis, vest one-third on each of the first three anniversaries of the 12/15/2016 grant date. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Exercise / conversionRestricted Stock Units · Derivative | 5,280 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · derivative · entry 8 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.01 · 5,280 shares Expires 2018-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: These restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Tax withholdingCommon Stock, par value $.01 | 8,451 | $2.84 | $24,000.84 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · nonDerivative · entry 6 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 F2 · shares: Shares withheld to cover tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Exercise / conversionCommon Stock, par value $.01 | 24,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · nonDerivative · entry 5 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: These restricted stock units, which convert into common stock on a one-for-one basis, vest one-third on each of the first three anniversaries of the 12/15/2017 grant date. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Tax withholdingCommon Stock, par value $.01 | 1,732 | $2.84 | $4,918.88 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · nonDerivative · entry 4 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,576 F2 · shares: Shares withheld to cover tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Exercise / conversionCommon Stock, par value $.01 | 5,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · nonDerivative · entry 3 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: These restricted stock units, which convert into common stock on a one-for-one basis, vest one-third on each of the first three anniversaries of the 12/15/2016 grant date. Read SEC document |
| December 15, 2018 Filed Dec 18, 2018 21:32 UTC | EASTMAN KODAK CO KODK · Entity 5053 | Tax withholdingCommon Stock, par value $.01 | 1,794 | $2.84 | $5,094.96 |
DisclosureSEC source: 0000891839-18-000120 · edgar.xml · nonDerivative · entry 2 Underberg Sharon E. · CIK 0001630353 · General Counsel, Sec., SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,212 F2 · shares: Shares withheld to cover tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.